The vaccine industry has been burgeoning since the late 1980s, when Congress passed the National Childhood Vaccine Injury Act (NCVIA) that provided manufacturers with blanket immunity from liability. Two regulatory agencies have played a pivotal role in this vaccine “renaissance”: the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Working hand in glove with vaccine companies, these agencies have helped protect and grow the liability-free childhood vaccine market, ensuring billions of dollars in corporate revenues with little need for vaccine makers to even advertise or market their products.
Although credible accusations have surfaced for years—aired by legislators, researchers, watchdog groups and many others—that both the FDA and CDC lack the impartiality required to make accurate judgments about vaccine safety, the two agencies continue with their business-as-usual practices. With vaccine promotion superseding vaccine safety monitoring as organizational goals, conflicts of interest are baked into both agencies’ DNA.
In this article, we examine the FDA’s role in licensing vaccines and ignoring vaccine injuries. The next article (Part V) will describe the crucial part played by the CDC in creating and promoting the bloated childhood vaccine schedule.
Read More: Here